Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Lancet Infect Dis ; 21(6): e141, 2021 06.
Article in English | MEDLINE | ID: covidwho-2265356
2.
Euro Surveill ; 26(3)2021 01.
Article in English | MEDLINE | ID: covidwho-1041841

ABSTRACT

When facing an emerging virus outbreak such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a quick reaction time is key to control the spread. It takes time to develop antivirals and vaccines, and implement vaccination campaigns. Therefore, preventive measures such as rapid isolation of cases and identification and early quarantine of cases' close contacts-as well as masks, physical distancing, hand hygiene, surface disinfection and air control-are crucial to reduce the risk of transmission. In this context, disinfectants and antiseptics with proven efficacy against the outbreak virus should be used. However, biocidal formulations are quite complex and may include auxiliary substances such as surfactants or emollients in addition to active substances. In order to evaluate disinfectants' efficacy objectively, meaningful efficacy data are needed. Therefore, the European Committee for Standardisation technical committee 216 'Chemical disinfectants and antiseptics' Working Group 1 (medical area) has developed standards for efficacy testing. The European tiered approach grades the virucidal efficacy in three levels, with corresponding marker test viruses. In the case of SARS-CoV-2, disinfectants with proven activity against vaccinia virus, the marker virus for the European claim 'active against enveloped viruses', should be used to ensure effective hygiene procedures to control the pandemic.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Anti-Infective Agents, Local/standards , COVID-19/prevention & control , Disinfectants/pharmacology , Disinfectants/standards , Preventive Medicine/standards , Virus Diseases/prevention & control , Guidelines as Topic , Humans , Pandemics/prevention & control , SARS-CoV-2
3.
Emerg Infect Dis ; 26(9): 2064-2068, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-381792

ABSTRACT

As a result of the coronavirus disease pandemic, commercial hand hygiene products have become scarce and World Health Organization (WHO) alcohol-based hand rub formulations containing ethanol or isopropanol are being produced for hospitals worldwide. Neither WHO formulation meets European Norm 12791, the basis for approval as a surgical hand preparation, nor satisfies European Norm 1500, the basis for approval as a hygienic hand rub. We evaluated the efficacy of modified formulations with alcohol concentrations in mass instead of volume percentage and glycerol concentrations of 0.5% instead of 1.45%. Both modified formulations met standard requirements for a 3-minute surgical hand preparation, the usual duration of surgical hand treatment in most hospitals in Europe. Contrary to the originally proposed WHO hand rub formulations, both modified formulations are appropriate for surgical hand preparation after 3 minutes when alcohol concentrations of 80% wt/wt ethanol or 75% wt/wt isopropanol along with reduced glycerol concentration (0.5%) are used.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Hand Hygiene/standards , Hand Sanitizers/standards , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , 2-Propanol/analysis , COVID-19 , Ethanol/analysis , Europe , Hand/microbiology , Hand Hygiene/methods , Hand Sanitizers/analysis , Humans , SARS-CoV-2 , World Health Organization
SELECTION OF CITATIONS
SEARCH DETAIL